- Tytuł:
- Tofacitinib as a biologic response modifier in VEXAS syndrome: A case series.
- Autorzy:
- Źródło:
- International journal of rheumatic diseases [Int J Rheum Dis] 2023 Nov; Vol. 26 (11), pp. 2340-2343. Date of Electronic Publication: 2023 Jun 19.
- Typ publikacji:
- Letter
- MeSH Terms:
-
Piperidines */adverse effects
Pyrimidines*/adverse effects
Humans ; Immunologic Factors ; Mutation - SCR Disease Name:
- VEXAS syndrome
Opinia redakcyjna